Search
Regulatory Story
Company Genus PLC
TIDM GNS
Headline Director/PDMR Shareholding
Released 15:11 04-Mar-2019
Number 7856R15

RNS Number : 7856R
Genus PLC
04 March 2019
 

4 March 2019

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that, further to the vesting of contingent rights over ordinary shares in Genus on 5 January 2019 under an individual restricted stock award agreement, Dr. Nate Zwald, a member of the Genus Executive Leadership Team, sold ordinary shares in Genus on 1 March 2019, on the London Stock Exchange to offset income tax and social security liabilities due on the exercise, and retained the balance of ordinary shares.

The below notification made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of contingent rights exercised and ordinary shares sold.

 

 

For further information please contact:

 

Genus:

Vaughn Walton, Interim Deputy Company Secretary                                                      Tel: +44 (0)1256 347100

 

 

 

Table A - GELT Restricted Stock Award Exercise

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Dr. Nate Zwald

2.           

Reason for the notification

a.           

Position/status

Chief Operating Officer, Genus ABS Dairy

b.           

Initial notification

/Amendment

Initial notification

3.           

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.          

LEI

54930022EOITNKSIGH56

4.           

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.           

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.           

Nature of the transaction

Acquisition of shares following exercise of 3,612 contingent rights under an individual restricted stock award agreement.

 

c.            

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

0p

3,612

  

d.           

Aggregated information

·     Aggregated volume

·     Price

 

 

Average price(s)

 

Total volume(s)

0p

3,612

e.           

Date of the transaction

2019-03-01

f.            

Place of the transaction

Outside a trading venue.

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.   

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

 

GB0002074580

b.   

b.

Nature of the transaction

Sale of 1,293 shares arising from the exercise of contingent rights under an individual restricted stock award agreement, to offset income tax and social security liabilities due on the exercise.

c.    

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

2,198.0404p

1,293

  

d.   

d.

Aggregated information

·     Aggregated volume

·     Price

 

 

Average price(s)

 

Total volume(s)

2,198.0404p

1,293

e.

Date of the transaction

2019-03-01

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUSAVRKRAORAR
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.